| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |